表紙:ヘルステックの世界市場:市場規模 - 技術別、コンポーネント別、エンドユーザー別、用途別、展開モード別、地域別展望、競合戦略、セグメント別予測(~2032年)
市場調査レポート
商品コード
1174970

ヘルステックの世界市場:市場規模 - 技術別、コンポーネント別、エンドユーザー別、用途別、展開モード別、地域別展望、競合戦略、セグメント別予測(~2032年)

HealthTech Market Size- By Technology, By Component, By End-User,By Applications,By Delivery Mode - Regional Outlook, Competitive Strategies and Segment Forecasts to 2032

出版日: | 発行: SPER Market Research Pvt. Ltd. | ページ情報: 英文 248 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ヘルステックの世界市場:市場規模 - 技術別、コンポーネント別、エンドユーザー別、用途別、展開モード別、地域別展望、競合戦略、セグメント別予測(~2032年)
出版日: 2022年12月07日
発行: SPER Market Research Pvt. Ltd.
ページ情報: 英文 248 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界のヘルステックの市場規模は、2032年までに1兆871億8,000万米ドルに達し、CAGRで18.22%の成長が予測されています。

支払い決済の迅速化に対する顧客ニーズの高まりや、IoTやクラウドベースソリューションなどの最先端技術の利用拡大により、市場は拡大しています。デジタルヘルス市場の拡大要因の1つは、モバイルプラットフォームの利用増加です。先進国における医療ITインフラの急速な改善、米国や欧州地域における政府の支援策の拡大、患者の遠隔モニタリングサービスの需要増加、ベンチャーキャピタルからの投資の拡大なども大きな促進要因となっています。

当レポートでは、世界のヘルステック市場について調査し、市場力学、市場変数と展望、技術・コンポーネント・エンドユーザー・用途・展開モード・地域別の市場分析、企業プロファイル等に関する情報を提供しています。

目次

第1章 イントロダクション

  • 調査範囲
  • 市場セグメント分析

第2章 調査手法

  • 調査データソース
  • 市場規模の推定
  • データの三角測量

第3章 エグゼクティブサマリー

第4章 市場力学

  • 促進要因、抑制要因、機会、課題の分析
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 世界のヘルステック市場におけるCOVID-19の影響

第5章 市場変数と展望

  • SWOT分析
    • 強み
    • 弱み
    • 機会
    • 脅威
  • PESTEL分析
    • 政治情勢
    • 経済情勢
    • 社会情勢
    • 技術情勢
    • 環境情勢
    • 法的情勢
  • ポーターのファイブフォース分析
    • 供給企業の交渉力
    • 買い手の交渉力
    • 代替品の脅威
    • 新規参入者の脅威
    • 競合企業間の敵対関係
  • ヒートマップ分析

第6章 世界のヘルステック市場:技術別(2019年~2032年(100万米ドル))

  • デジタルヘルスシステム
    • 電子処方箋システム
    • 電子カルテ
  • ヘルス分析
  • 健康情報技術(HIT)
  • mヘルス
    • アプリ
    • ウェアラブル
  • テレヘルスケア
    • テレヘルス
    • テレケア
    • テレメディシン

第7章 世界のヘルステック市場:コンポーネント別(2019年~2032年(100万米ドル))

  • ハードウェア
  • ソフトウェア
  • サービス

第8章 世界のヘルステック市場:エンドユーザー別(2019年~2032年(100万米ドル))

  • 医療提供者
  • 医療保険業者
  • 医療消費者
  • 製薬企業
  • その他

第9章 世界のヘルステック市場:用途別(2019年~2032年(100万米ドル))

  • 心臓病
  • 糖尿病
  • 神経
  • 睡眠時無呼吸症候群
  • 腫瘍
  • その他

第10章 世界のヘルステック市場:展開モード別(2019年~2032年(100万米ドル))

  • クラウドベース
  • オンプレミス

第11章 世界のヘルステック市場:地域別(2019年~2032年(100万米ドル))

  • 北米
    • カナダ
    • メキシコ
    • 米国
  • 欧州
    • フランス
    • ドイツ
    • イタリア
    • その他の欧州
    • スペイン
    • 英国
  • アジア太平洋
    • オーストラリア
    • 中国
    • インド
    • 日本
    • その他のアジア太平洋
    • 韓国
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米
  • 中東・アフリカ
    • サウジアラビア王国
    • アラブ首長国連邦
    • その他の中東・アフリカ

第12章 企業プロファイル

  • AirStrip Technologies
    • 企業概要
    • 財務展望
    • 製品概要
    • 最近の開発
  • Allscripts
  • Apple Inc.
  • AT&T
  • Cerner Corporation (Oracle)
  • CISCO Systems Inc.
  • Epic Systems Corporation
  • Google Inc.
  • HiMS
  • IBM Corporation
  • MQure
  • McKesson Corporation
  • MDlive
  • Medi Buddy
  • Medical device as a service (MDAAS)
  • MedPass
  • Mobicure
  • Myndtec
  • NeurNation
  • Nutrino
  • Okadoc
  • Omnia Salud
  • Pharm Easy
  • Philip Healthcare
  • Polycom Inc
  • Safermom
  • System Healthcare Solutions
  • Takalam
  • Teladoc
  • TeleMD
  • UAE's Mulk
  • Ubenwa
  • Welli
  • Wuru
  • Xtreme VRI
  • Yerbo
目次
Product Code: HLCA2223

Global HealthTech Market Overview:

According to SPER Market Research, the Global HealthTech Market is estimated to reach USD 1087.18 billion by 2032 with a CAGR of 18.22%.

The market for Health Techs is expanding as a result of increased customer demand for speedier payment settlements and rising use of cutting-edge technology like IoT and cloud-based solutions. One of the main drivers of the digital health market's expansion is the rise in the use of smartphones, tablets, and other mobile platforms. Other significant drivers include the rapidly improving healthcare IT infrastructure in industrialised countries, the expansion of supportive government initiatives in the U.S. and European region, the rise in demand for remote patient monitoring services, and the growth of venture capital investments. Further expanding the market for digital health throughout the aforementioned projected period will be an increase in technical development, modernization of the digitization, research and development activities, and demand from emerging economies.

Impact of COVID-19 on the Global HealthTech Market

Nearly every business has been impacted by the unmatched worldwide public health emergency known as COVID-19, and the long-term impacts are expected to have an influence on industry growth throughout the course of the projection period.The COVID-19 pandemic outbreak is projected to have a significant impact on the market for Health Techs. The market is anticipated to grow faster during the forecast period due to the surge in demand for virtual consultation services using mHealth applications, teleconsultation, electronic medical records, and virtual fitness platforms, as well as the quick-moving technological advancements.Additionally, the post-pandemic market growth is expected to be fuelled by manufacturer's growing development of next-generation low-cost platforms, such as telemedicine, mHealth, telehealth, and telecare services.The rapid acceleration of market growth was influenced by a number of healthcare-related factors, including mHealth, telecare, patient management, advanced diagnostics, digital integration of health systems, and raising cybersecurity requirements. Telemedicine and other digital health technologies provide healthcare providers excellent opportunities to treat patients while observing lockdown protocols.

Scope of the Report:

  • Market size available for years: 2019-2032
  • Base year considered: 2021
  • Forecast period: 2022-2032
  • Segments covered: By Technology, By Component, By End-User, By Applications, By Delivery Mode
  • Regions covered: North America, Europe, Asia Pacific, Latin America, Middle East and Africa
  • Companies Covered: AirStrip Technologies, Allscripts, Apple Inc., AT&T, Cerner Corporation (Oracle), CISCO Systems Inc, Epic Systems Corporation, Google Inc., HiMS, IBM Corporation, Mqure, McKesson Corporation, Mdlive, Medi Buddy, Medical device as a service (MDAAS), MedPass, Mobicure, Myndtec, NeurNation, Nutrino, Okadoc, Omnia Salud, Pharm Easy, Philip Healthcare, Polycom Inc, Safermom, System Healthcare Solutions, Takalam, TeleMD, UAE's Mulk, Ubenwa, Welli, Wuru, Xtreme VRI, Yerbo

Global Health Tech Market Segmentation:

  • By Technology: Based on the Technology, Global Health Tech Market is segmented as; Digital Health Systems (E-prescribing Systems and Electronic Health Records), Health Analytics, Health Information Technology, mHealth {Apps (Medical Apps, Fitness Apps, Services), Wearables (Activity Trackers/Actigraphs, BP Monitors, Glucose Meter, Neurological Monitors, Pulse Oximeter,Sleep Apnea Monitors)}, Telehealthcare {Telehealth (LTC Monitoring, Video Consultation), Telecare (Activity Monitoring,Remote Medication Management), Telemedicine}.
  • By Component: Based on the Component, Global Health Tech Market is segmented as; Hardware, Software and Services.
  • By End-User: Based on the End-User, Global Health Tech Market is segmented as; Healthcare Providers, Healthcare Payers, Healthcare Consumers, Pharmaceutical Companies and Others.
  • By Applications: Based on the Applications, Global Health Tech Market is segmented as; Cardiology, Diabetes, Neurology, Sleep Apnea, Oncology and Others.
  • By Delivery Modes: Based on the Delivery Modes, Global Health Tech Market is segmented as;Cloud and On-premises.
  • By Region: The region with the fastest growth rate is predicted to be Asia Pacific. The region's expanding eHealth platform adoption and rising healthcare spending are anticipated to fuel the expansion of these services. Government investment on healthcare is predicted to enhance demand for remote patient monitoring and other telehealth services, which will fuel industry growth in the Asia Pacific region.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1 Research data source
    • 2.1.1 Secondary data
    • 2.1.2 Primary data
    • 2.1.3 SPER's internal database
    • 2.1.4 Premium insight from KOL's
  • 2.2 Market size estimation
    • 2.2.1 Top-down and Bottom-up approach
  • 2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1 Drivers
    • 4.1.2 Restraints
    • 4.1.3 Opportunities
    • 4.1.4 Challenges
  • 4.2. COVID-19 Impacts of the Global Health Tech Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1 Strengths
    • 5.1.2 Weaknesses
    • 5.1.3 Opportunities
    • 5.1.4 Threats
  • 5.2. PESTEL analysis
    • 5.2.1 Political landscape
    • 5.2.2 Economic landscape
    • 5.2.3 Social landscape
    • 5.2.4 Technological landscape
    • 5.2.5 Environmental landscape
    • 5.2.6 Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1 Bargaining power of suppliers
    • 5.3.2 Bargaining power of Buyers
    • 5.3.3 Threat of Substitute
    • 5.3.4 Threat of new entrant
    • 5.3.5 Competitive rivalry
  • 5.4.Heat map analysis

6. Global Health Tech Market, By Technology, 2019-2032 (USD Million)

  • 6.1. Digital Health Systems
    • 6.1.1. E-Prescribing Systems
    • 6.1.2. Electronic Health Records
  • 6.2. Health Analytics
  • 6.3. Health Information Technology
  • 6.4. mHealth
    • 6.4.1. Apps
      • 6.4.1.1. Medical Apps
      • 6.4.1.2. Fitness Apps
      • 6.4.1.3. Services
    • 6.4.2. Wearables
      • 6.4.2.1. Activity Trackers/Actigraphs
      • 6.4.2.2. BP Monitors
      • 6.4.2.3. Glucose Meter
      • 6.4.2.4. Neurological Monitors
      • 6.4.2.5. Pulse Oximeter
      • 6.4.2.6. Sleep Apnea Monitors
  • 6.5. Telehealthcare
    • 6.5.1. Telehealth
      • 6.5.1.1. LTC Monitoring
      • 6.5.1.2. Video Consultation
    • 6.5.2. Telecare
      • 6.5.2.1. Activity Monitoring
      • 6.5.2.2. Remote Medication Management
    • 6.5.3. Telemedicine

7. Global Health Tech Market, By Component, 2019-2032 (USD Million)

  • 7.1. Hardware
  • 7.2. Software
  • 7.3. Services

8. Global Health Tech Market, By End-User, 2019-2032 (USD Million)

  • 8.1. Healthcare Providers
  • 8.2. Healthcare Payers
  • 8.3. Healthcare Consumers
  • 8.4. Pharmaceutical Companies
  • 8.5. Others

9. Global Health Tech Market, By Applications, 2019-2032 (USD Million)

  • 9.1. Cardiology
  • 9.2. Diabetes
  • 9.3. Neurology
  • 9.4. Sleep Apnea
  • 9.5. Oncology
  • 9.6. Others

10. Global Health Tech Market, By Delivery Modes, 2019-2032 (USD Million)

  • 10.1. Cloud-Based
  • 10.2. On-premises

11. Global Health Tech Market, By Region, 2019-2032 (USD Million)

  • 11.1. North America
    • 11.1.1. Canada
    • 11.1.2. Mexico
    • 11.1.3. United States
  • 11.2. Europe
    • 11.2.1. France
    • 11.2.2. Germany
    • 11.2.3. Italy
    • 11.2.4. Rest of Europe
    • 11.2.5. Spain
    • 11.2.6. United Kingdom
  • 11.3. Asia-Pacific
    • 11.3.1. Australia
    • 11.3.2. China
    • 11.3.3. India
    • 11.3.4. Japan
    • 11.3.5. Rest of Asia-Pacific
    • 11.3.6. South Korea
  • 11.4. South America
    • 11.4.1. Brazil
    • 11.4.2. Argentina
    • 11.4.3. Rest of South America
  • 11.5. Middle East & Africa
    • 11.5.1. Kingdom of Saudi Arabia
    • 11.5.2. United Arab Emirates
    • 11.5.3. Rest of Middle East & Africa

12. Company Profiles

  • 12.1. AirStrip Technologies
    • 12.1.1. Company details
    • 12.1.2. Financial outlook
    • 12.1.3. Product summary
    • 12.1.4. Recent developments
  • 12.2. Allscripts
    • 12.2.1. Company details
    • 12.2.2. Financial outlook
    • 12.2.3. Product summary
    • 12.2.4. Recent developments
  • 12.3. Apple Inc.
    • 12.3.1. Company details
    • 12.3.2. Financial outlook
    • 12.3.3. Product summary
    • 12.3.4. Recent developments
  • 12.4. AT&T
    • 12.4.1. Company details
    • 12.4.2. Financial outlook
    • 12.4.3. Product summary
    • 12.4.4. Recent developments
  • 12.5. Cerner Corporation (Oracle)
    • 12.5.1. Company details
    • 12.5.2. Financial outlook
    • 12.5.3. Product summary
    • 12.5.4. Recent developments
  • 12.6. CISCO Systems Inc.
    • 12.6.1. Company details
    • 12.6.2. Financial outlook
    • 12.6.3. Product summary
    • 12.6.4. Recent developments
  • 12.7. Epic Systems Corporation
    • 12.7.1. Company details
    • 12.7.2. Financial outlook
    • 12.7.3. Product summary
    • 12.7.4. Recent developments
  • 12.8. Google Inc.
    • 12.8.1. Company details
    • 12.8.2. Financial outlook
    • 12.8.3. Product summary
    • 12.8.4. Recent developments
  • 12.9. HiMS
    • 12.9.1. Company details
    • 12.9.2. Financial outlook
    • 12.9.3. Product summary
    • 12.9.4. Recent developments
  • 12.10. IBM Corporation
    • 12.10.1. Company details
    • 12.10.2. Financial outlook
    • 12.10.3. Product summary
    • 12.10.4. Recent developments
  • 12.11. MQure
    • 12.11.1. Company details
    • 12.11.2. Financial outlook
    • 12.11.3. Product summary
    • 12.11.4. Recent developments
  • 12.12. McKesson Corporation
    • 12.12.1. Company details
    • 12.12.2. Financial outlook
    • 12.12.3. Product summary
    • 12.12.4. Recent developments
  • 12.13. MDlive
    • 12.13.1. Company details
    • 12.13.2. Financial outlook
    • 12.13.3. Product summary
    • 12.13.4. Recent developments
  • 12.14. Medi Buddy
    • 12.14.1. Company details
    • 12.14.2. Financial outlook
    • 12.14.3. Product summary
    • 12.14.4. Recent developments
  • 12.15. Medical device as a service (MDAAS)
    • 12.15.1. Company details
    • 12.15.2. Financial outlook
    • 12.15.3. Product summary
    • 12.15.4. Recent developments
  • 12.16. MedPass
    • 12.16.1. Company details
    • 12.16.2. Financial outlook
    • 12.16.3. Product summary
    • 12.16.4. Recent developments
  • 12.17. Mobicure
    • 12.17.1. Company details
    • 12.17.2. Financial outlook
    • 12.17.3. Product summary
    • 12.17.4. Recent developments
  • 12.18. Myndtec
    • 12.18.1. Company details
    • 12.18.2. Financial outlook
    • 12.18.3. Product summary
    • 12.18.4. Recent developments
  • 12.19. NeurNation
    • 12.19.1. Company details
    • 12.19.2. Financial outlook
    • 12.19.3. Product summary
    • 12.19.4. Recent developments
  • 12.20. Nutrino
    • 12.20.1. Company details
    • 12.20.2. Financial outlook
    • 12.20.3. Product summary
    • 12.20.4. Recent developments
  • 12.21. Okadoc
    • 12.21.1. Company details
    • 12.21.2. Financial outlook
    • 12.21.3. Product summary
    • 12.21.4. Recent developments
  • 12.22. Omnia Salud
    • 12.22.1. Company details
    • 12.22.2. Financial outlook
    • 12.22.3. Product summary
    • 12.22.4. Recent developments
  • 12.23. Pharm Easy
    • 12.23.1. Company details
    • 12.23.2. Financial outlook
    • 12.23.3. Product summary
    • 12.23.4. Recent developments
  • 12.24. Philip Healthcare
    • 12.24.1. Company details
    • 12.24.2. Financial outlook
    • 12.24.3. Product summary
    • 12.24.4. Recent developments
  • 12.25. Polycom Inc
    • 12.25.1. Company details
    • 12.25.2. Financial outlook
    • 12.25.3. Product summary
    • 12.25.4. Recent developments
  • 12.26. Safermom
    • 12.26.1. Company details
    • 12.26.2. Financial outlook
    • 12.26.3. Product summary
    • 12.26.4. Recent developments
  • 12.27. System Healthcare Solutions
    • 12.27.1. Company details
    • 12.27.2. Financial outlook
    • 12.27.3. Product summary
    • 12.27.4. Recent developments
  • 12.28. Takalam
    • 12.28.1. Company details
    • 12.28.2. Financial outlook
    • 12.28.3. Product summary
    • 12.28.4. Recent developments
  • 12.29. Teladoc
    • 12.29.1. Company details
    • 12.29.2. Financial outlook
    • 12.29.3. Product summary
    • 12.29.4. Recent developments
  • 12.30. TeleMD
    • 12.30.1. Company details
    • 12.30.2. Financial outlook
    • 12.30.3. Product summary
    • 12.30.4. Recent developments
  • 12.31. UAE's Mulk
    • 12.31.1. Company details
    • 12.31.2. Financial outlook
    • 12.31.3. Product summary
    • 12.31.4. Recent developments
  • 12.32. Ubenwa
    • 12.32.1. Company details
    • 12.32.2. Financial outlook
    • 12.32.3. Product summary
    • 12.32.4. Recent developments
  • 12.33. Welli
    • 12.33.1. Company details
    • 12.33.2. Financial outlook
    • 12.33.3. Product summary
    • 12.33.4. Recent developments
  • 12.34. Wuru
    • 12.34.1. Company details
    • 12.34.2. Financial outlook
    • 12.34.3. Product summary
    • 12.34.4. Recent developments
  • 12.35. Xtreme VRI
    • 12.35.1. Company details
    • 12.35.2. Financial outlook
    • 12.35.3. Product summary
    • 12.35.4. Recent developments
  • 12.36. Yerbo
    • 12.36.1. Company details
    • 12.36.2. Financial outlook
    • 12.36.3. Product summary
    • 12.36.4. Recent developments